Estech Pharma
VC Fund
Seocho, South Korea
Estech Pharma is a raw material pharmaceutical company.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Estech Pharma invests in
Stages Estech Pharma invests in
Countries Estech Pharma invests in
Investment Focus
Industry
- Medical 2 (50%)
- Electronics 1 (25%)
- Health Care 1 (25%)
- Biotechnology 1 (25%)
- Pharmaceutical 1 (25%)
Stage
- Series A 2 (50%)
- Series B 1 (25%)
- Funding Round 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Bilix
|
Bilix is a biotechnology company that produces anti-inflammatory and cancer therapy drugs for inflammatory diseases. Bilix, developer of PEGylated bilirubin nanoparticles designed to treat ischemia-reperfusion injury by reducing inflammation and oxidative stress. | Series B / Jul 17, 2025 | |
|
Bilix
|
Bilix is a biotechnology company that produces anti-inflammatory and cancer therapy drugs for inflammatory diseases. Bilix, developer of PEGylated bilirubin nanoparticles designed to treat ischemia-reperfusion injury by reducing inflammation and oxidative stress. | $12.5M / Series A / May 25, 2021 | |
The Wave Talk
|
The.Wave.Talk developed a biosensor that can detect and monitor impurities (bacteria) within a second. 420,000 people die of food-borne disease per year. Moreover, 10 million people will die of antimicrobial resistance by 2050. It's all about bacteria. It is the origin of life and 5 million-trillion-trillion bacteria are living together withus today. Bacteria are everywhere and every-time. Comparing to this, conventional technologies can detect bacteria only with sampling manner. Because they take long time(several hours up-to days) even with expensive tools. | $1.3M / Series A / Mar 04, 2018 | |
|
The Wave Talk
|
The.Wave.Talk developed a biosensor that can detect and monitor impurities (bacteria) within a second. 420,000 people die of food-borne disease per year. Moreover, 10 million people will die of antimicrobial resistance by 2050. It's all about bacteria. It is the origin of life and 5 million-trillion-trillion bacteria are living together withus today. Bacteria are everywhere and every-time. Comparing to this, conventional technologies can detect bacteria only with sampling manner. Because they take long time(several hours up-to days) even with expensive tools. | Apr 11, 2017 |
Co-Investors
DS Asset Management
2 deals together
Genaxis
2 deals together
Industrial Bank of Korea
2 deals together
Magna Investment
2 deals together
Naver
2 deals together
Soulbrain Holdings
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Estech Pharma invest in?
Estech Pharma invests primarily in Medical, Electronics and Health Care startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Estech Pharma last invest?
The most recent investment recorded for Estech Pharma closed in Jul 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
